incid
hospit
childhood
pneumonia
declin
countri
introduc
pneumococc
conjug
vaccin
pcv
popul
rate
complic
pneumonia
increas
last
two
decad
although
still
rel
uncommon
occur
children
cap
incid
allcaus
empyema
increas
unit
state
us
children
age
year
rose
case
per
case
per
pneumococci
staphylococcu
aureu
common
pathogen
detect
utah
incid
pediatr
pneumococc
empyema
increas
per
per
immedi
prior
introduc
pcv
reach
per
increas
due
almost
exclus
nonvaccin
serotyp
signific
increas
complic
pneumonia
also
report
unit
kingdom
uk
europ
australia
israel
although
latter
studi
increas
np
case
statist
signific
increas
per
almost
per
singl
tertiari
pediatr
center
also
report
tempor
increas
pediatr
np
case
number
french
studi
found
np
contribut
cap
case
hospit
cap
age
year
rate
np
complic
hospit
cap
doubl
respect
studi
uk
us
report
similar
increas
np
case
first
decad
centuri
report
increas
np
rate
among
children
cultureconfirm
blood
pleural
fluid
lung
tissu
bronchoalveolar
lavag
fluid
pneumococc
pneumonia
also
appear
center
utah
taiwan
proport
children
np
rose
respect
reason
chang
epidemiolog
complex
like
reflect
heighten
awar
well
tempor
chang
organ
antibiot
prescrib
pattern
case
np
children
occur
global
report
north
america
latin
america
uk
europ
middl
east
asia
australia
tabl
show
typic
child
either
np
pnp
age
year
except
studi
taiwan
equal
like
male
femal
surprisingli
children
underli
comorbid
asthma
common
chronic
disord
identifi
retrospect
prospect
studi
identifi
risk
factor
associ
complic
pneumonia
one
includ
case
identifi
np
particular
studi
hospit
children
cap
complic
analyz
risk
factor
combin
children
empyema
anoth
four
lung
abscess
consequ
contrast
cap
possibl
current
clearli
identifi
risk
factor
specif
associ
np
although
may
biolog
plausibl
whenev
evalu
preadmiss
ibuprofen
identifi
signific
independ
risk
factor
associ
complic
pneumonia
even
adjust
potenti
confound
age
sex
symptom
durat
although
confound
indic
could
exclud
receiv
nonsteroid
antiinflammatori
agent
might
mask
pain
fever
propos
might
lead
delay
present
treatment
rather
agent
impair
child
immun
respons
infect
suggest
expert
common
pathogen
associ
np
children
pneumococci
aureu
bacteri
fungal
pathogen
detect
singl
case
report
case
seri
cite
review
pneumococci
aureu
includ
methicillinresist
aureu
mrsa
strain
addit
pediatr
case
seri
restrict
either
pnp
n
isol
see
tabl
aureu
n
isol
alon
pneumococci
possess
multipl
virul
factor
includ
polysaccharid
capsul
cell
surfac
protein
cell
wall
pneumolysin
poreform
toxin
import
polysaccharid
capsul
least
differ
serotyp
capabl
shield
organ
immun
system
individu
serotyp
vari
capac
colon
caus
local
invas
diseas
express
antibiot
resist
gene
serotyp
also
vari
geograph
chang
time
perhap
respons
local
ecolog
competit
pressur
organ
cohabit
nasopharyng
space
well
select
pressur
antibiot
pcv
inde
pneumococc
serotyp
associ
pnp
tabl
includ
pcv
notabl
serotyp
reflect
possibl
tempor
shift
circul
serotyp
andor
vaccineinduc
strain
replac
diseas
serotyp
close
associ
pnp
serotyp
thick
capsul
strongli
resist
opsonophagocytosi
induc
mark
inflammatori
respons
includ
intens
neutrophil
infiltr
suppur
necrosi
contrast
serotyp
strain
greater
invas
potenti
may
growth
advantag
pneumococc
serotyp
normal
steril
site
often
resist
multipl
antibiot
aureu
also
mani
virul
factor
help
instig
colon
evad
hostimmun
respons
caus
tissu
injuri
dissemin
organ
establish
infect
aureu
express
surfac
protein
mediat
adher
impair
local
defenc
later
infect
secret
exotoxin
disrupt
epitheli
barrier
immun
cell
function
respons
therebi
facilit
tissu
invas
although
long
recogn
import
caus
np
interest
pathogen
renew
recent
studi
link
strain
express
virul
factor
pantonvalentin
leukocidin
pvl
sever
form
diseas
previous
healthi
children
adult
mani
case
pvlproduc
isol
also
mrsa
strain
pvl
poreform
exotoxin
activ
destroy
immun
cell
neutrophil
potenti
releas
damag
proteas
surround
tissu
concern
multicent
french
studi
involv
case
np
caus
pvlproduc
strain
aureu
children
adult
age
month
year
report
case
fatal
rate
factor
associ
mortal
hemoptysi
erythemat
rash
within
h
admiss
peripher
blood
leukopenia
howev
noncompar
studi
therefor
difficult
infer
whether
pvl
contribut
pathogen
inde
whether
pvl
respons
patholog
chang
seen
np
controversi
part
pvl
strong
cell
speci
specif
behav
differ
variou
cell
cultur
experiment
model
exampl
neutrophil
human
rabbit
sensit
effect
pvl
vitro
monkey
mice
highli
resist
moreov
systemat
review
metaanalysi
found
strong
associ
pvlproduc
strain
aureu
skin
soft
tissu
infect
associ
seen
invas
infect
includ
pneumonia
howev
review
limit
includ
one
small
studi
children
china
compar
case
mrsa
cap
signific
differ
proport
pvlposit
neg
strain
progress
np
respect
similarli
link
np
mrsa
also
contenti
mani
observ
studi
report
associ
invas
diseas
mrsa
us
pvlproduc
mrsa
clone
predomin
europ
australasia
elsewher
mani
differ
mrsa
strain
circul
furthermor
recent
casecontrol
studi
french
children
adult
pvlposit
strain
aureu
np
found
evid
increas
clinic
sever
mrsa
infect
consequ
substanti
gap
knowledg
concern
pathogenesi
aureu
np
like
cytotoxin
play
import
role
inde
attent
focus
recent
poreform
toxin
includ
alphahemolysin
propos
mechan
action
includ
activ
inflammasom
result
sever
alveolar
necrosi
induc
plateletneutrophil
aggreg
lead
tissu
destruct
addit
pneumococci
aureu
respiratori
bacteri
fungal
pathogen
report
occasion
studi
includ
present
review
streptococcu
pyogen
n
member
anginosu
group
n
haemophilu
influenza
n
pseudomona
aeruginosa
n
stenotrophomona
maltophilia
n
anaerob
organ
fusobacterium
nucleatum
n
mycoplasma
pneumonia
n
legionella
pneumophila
n
aspergillu
speci
n
unlik
adult
klebsiella
pneumonia
common
caus
np
children
contrast
simpl
pulmonari
abscess
oral
anaerob
report
rare
howev
also
acknowledg
mani
case
seri
may
undertaken
anaerob
cultur
nevertheless
adult
experi
anaerob
play
minor
role
virus
even
associ
outbreak
sever
adenoviru
pneumonia
rare
sole
caus
np
contrast
associ
respiratori
syncyti
viru
rsv
influenza
viru
infect
increas
nasopharyng
colon
pneumococci
aureu
greater
risk
secondari
bacteri
cap
enhanc
sever
well
recogn
howev
studi
np
children
collect
inform
respiratori
virus
surpris
given
consist
report
influenzalik
ill
occur
immedi
prior
np
caus
pvlproduc
strain
aureu
singl
case
report
np
associ
either
rsv
influenza
alon
associ
mrsa
pneumococci
studi
systemat
test
respiratori
virus
limit
one
seri
children
pnp
respiratori
virus
rhinoviru
n
influenza
n
parainfluenza
n
human
coronaviru
detect
upper
airway
polymeras
chain
reaction
pcr
assay
anoth
small
studi
report
children
pnp
complic
hemolyt
urem
syndrom
hu
posit
viral
cultur
influenza
n
one
adenoviru
plu
enteroviru
parainfluenza
human
metapneumoviru
mechan
associ
interact
within
respiratori
tract
complex
multilay
incomplet
understood
beyond
scope
review
virus
decreas
bacteri
clearanc
disrupt
respiratori
epitheli
barrier
impair
mucociliari
function
increas
bacteri
adher
upregul
adher
protein
modul
immun
function
interf
critic
compon
innat
immun
system
downregul
macrophag
phagocytosi
decreas
neutrophil
intracellular
kill
induc
apoptosi
interact
predispos
cap
includ
np
still
unknown
import
understand
devis
public
health
prevent
strategi
seek
optim
individu
patient
manag
histopatholog
find
autopsi
surgic
lung
specimen
adult
children
np
character
necrosi
lung
parenchyma
thought
primarili
vascular
process
trigger
infect
lead
vascul
activ
coagul
system
thrombot
occlus
intrapulmonari
vessel
accompani
caviti
format
howev
age
group
intens
suppur
also
seen
postul
direct
cytotox
effect
bacteri
toxin
secondarili
induc
intens
cytokinemedi
inflammatori
respons
includ
mediat
neutrophil
recruit
activ
releas
proteolyt
enzym
also
contribut
tissu
injuri
destruct
mixtur
coagul
liquefact
lung
necrosi
lead
one
thinwal
caviti
form
pneumatocel
oneway
passag
ga
evolv
pulmonari
abscess
ppe
empyema
also
common
necrot
region
extend
pleura
bpf
may
form
result
persist
ga
leak
commun
lung
pleural
space
especi
follow
surgic
intervent
rare
ischemia
secondari
simultan
thrombos
multipl
intrapulmonari
vessel
result
pulmonari
gangren
entir
lobe
late
diseas
phenomenon
recogn
commonli
adult
children
np
young
age
year
healthi
previous
tabl
clinic
featur
pneumonia
fever
cough
chest
pain
tachypnea
local
chest
sign
may
includ
percuss
dull
decreas
breath
sound
andor
bronchial
breath
symptom
may
present
sever
day
present
tabl
despit
receiv
appropri
therapi
children
often
disproportion
sick
persist
fever
respiratori
distress
clinic
andor
radiograph
sign
nonrespond
progress
pneumonia
accompani
ppe
empyema
bpf
diagnos
either
pneumothorax
chest
radiograph
persist
h
ga
leak
chest
tube
also
frequent
complic
tabl
much
rarer
complic
hu
lead
microangipath
hemolyt
anemia
thrombocytopenia
acut
renal
failur
within
day
symptom
onset
taiwanes
studi
report
pnp
associ
hu
especi
serotyp
pneumococc
strain
possess
neuraminidas
gene
nanc
whose
enzym
product
cleav
sialic
acid
residu
surfac
red
blood
cell
platelet
endotheli
cell
np
frequent
associ
elev
inflammatori
marker
includ
high
peripher
white
blood
cell
count
pnp
creactiv
protein
level
exceed
mgl
mildtomoder
anemia
hypoalbuminemia
also
common
tabl
pleural
fluid
typic
featur
empyema
either
frank
pu
visibl
organ
gram
stain
increas
white
blood
cell
predominantli
neutrophil
character
ph
protein
gl
glucos
level
mmoll
lactat
dehydrogenas
concentr
often
ul
latter
reflect
lung
parenchym
injuri
contrast
pleural
fluid
patient
pneumoniaassoci
np
high
protein
content
normal
glucos
concentr
often
predomin
lymphocyt
diagnosi
np
alway
consid
child
pneumonia
remain
unwel
despit
least
h
appropri
antibiot
particularli
import
evid
bpf
ppe
locul
empyema
present
undergon
drainag
surgic
manag
without
improv
extrapulmonari
site
infect
skin
soft
tissu
musculoskelet
system
sought
occasion
children
np
deterior
rapidli
follow
initi
present
featur
sever
sepsi
includ
septic
shock
multiorgan
failur
hypox
respiratori
failur
onset
pulmonari
hemorrhag
hemoptysi
erythemat
rash
declin
peripher
white
blood
cell
count
omin
sign
associ
strongli
exclus
aureu
infect
np
consid
sever
radiograph
microbiolog
studi
help
make
diagnosi
identifi
caus
organ
respect
although
chest
radiograph
demonstr
underli
pneumonia
accompani
ppe
result
mediastin
shift
investig
diagnost
children
np
one
small
lucenc
pneumatocel
fig
b
fig
b
seen
median
day
follow
hospit
poor
sensit
chest
radiograph
result
cavitori
lesion
fill
fluid
follow
liquefact
necrosi
densiti
adjac
consolid
lung
lesion
becom
visibl
later
cours
np
necrot
fluid
drain
commun
bronchi
replac
ga
contrastenhanc
chest
ct
scan
sensit
chest
radiograph
becom
standard
imag
procedur
make
diagnosi
np
evalu
lung
parenchyma
chang
visibl
plain
chest
radiograph
determin
whether
underli
congenit
lung
malform
exist
key
diagnost
featur
poor
absent
vascular
loss
pulmonari
architectur
final
caviti
format
multipl
small
ga
fluidfil
thinwal
caviti
usual
seen
initi
often
involv
singl
lobe
nonenhanc
indic
reduc
perfus
fig
locul
fluid
ga
within
pleural
caviti
also
gener
present
lung
undergo
liquefact
necrosi
multipl
small
caviti
may
coalesc
form
larger
caviti
includ
gasfil
pneumatocel
develop
later
stage
np
nevertheless
controversi
interpret
radiograph
find
remain
includ
defin
caviti
term
wall
thick
exampl
lung
abscess
evolv
np
thick
wall
addit
contrast
enhanc
often
gasfluid
level
differenti
pleural
parenchym
space
difficult
ppe
adjac
area
liquefi
lung
ct
scan
also
without
limit
includ
exposur
ioniz
radiat
cost
feasibl
critic
ill
patient
avail
poorli
resourc
set
ultrasonographi
primari
imag
modal
evalu
pleural
space
children
complic
pneumonia
also
identifi
consolid
lung
combin
color
doppler
detect
hypoperfus
region
lung
retrospect
studi
found
good
correl
r
ct
scan
result
children
cap
evid
np
lung
ultrasonographi
attract
featur
portabl
radiat
exposur
low
cost
wide
avail
need
sedat
young
patient
therefor
consid
perform
ct
scan
neither
safe
feasibl
earli
diagnosi
np
influenc
patient
manag
detect
hypoecho
lesion
fig
impair
region
perfus
use
combin
lung
ultrasonographi
color
doppler
predict
high
likelihood
underli
np
pneumatocel
format
nevertheless
imag
techniqu
still
operatordepend
collater
circul
area
necrosi
ventilationperfus
mismatch
within
consolid
lung
may
also
affect
sensit
specif
respect
peripher
blood
cultur
serolog
test
pathogen
pneumonia
pleural
fluid
investig
includ
gram
stain
cultur
cultureindepend
test
pcr
rapid
antigen
assay
use
establish
etiolog
caus
pleural
fluid
provid
greatest
microbiolog
yield
tabl
especi
use
sensit
molecular
diagnost
rapid
antigen
techniqu
pleural
fluid
obtain
time
insert
intercost
tube
drain
pleural
space
time
surgeri
even
intercost
needl
aspir
ppe
present
sputum
cultur
gener
achiev
unreli
potenti
pathogen
pneumococci
found
frequent
healthi
children
similarli
identifi
virus
respiratori
secret
import
gain
understand
pathogenesi
np
possibl
infect
control
measur
posit
result
unlik
major
influenc
manag
discontinu
antibiot
detect
virus
mean
caus
underli
np
studi
children
np
display
tabl
show
posit
microbiolog
result
case
demonstr
challeng
make
microbiolog
diagnosi
mani
children
receiv
antibiot
hospit
one
studi
reduc
posit
cultur
result
without
antibiot
receiv
hospit
moreov
clinician
reli
heavili
upon
tradit
cultur
method
identifi
like
caus
pathogen
studi
greatest
microbiolog
yield
came
us
franc
uk
howev
us
studi
includ
four
case
posit
blood
cultur
coagulaseneg
staphylococci
like
contamin
case
posit
pneumococc
cultur
unknown
number
origin
sputum
importantli
studi
found
pleural
fluid
sampl
produc
posit
pneumococc
antigen
result
highlight
use
test
french
studi
children
aureu
np
posit
blood
cultur
posit
pleural
fluid
cultur
posit
protectedbrush
specimen
bronchoalveolar
lavag
cultur
organ
respect
children
pnp
posit
blood
cultur
pneumococci
cultur
pleural
fluid
studi
import
test
pleural
fluid
shown
f
nucleatum
detect
pcr
test
small
select
uk
surgic
studi
also
rel
high
diagnost
yield
pcr
cultur
pleural
fluid
despit
receiv
antibiot
sever
day
previous
thu
diagnost
difficulti
associ
prior
antibiot
low
organ
load
steril
site
may
address
sensit
molecular
techniqu
within
laboratori
pcr
employ
detect
pneumococci
pleural
fluid
yet
establish
test
blood
specimen
offer
hope
futur
similarli
rapid
diagnost
test
broad
rang
respiratori
pathogen
undergo
develop
although
differenti
carriag
diseas
sampl
nonsteril
site
remain
major
limit
noninvas
test
broad
rang
disord
caus
pulmonari
caviti
tabl
children
np
import
differenti
diagnos
includ
infect
associ
lung
caviti
secondarili
infect
congenit
lung
abnorm
traumat
pseudocyst
underli
unsuspect
primari
immunodefici
uncommon
patient
np
suspect
histori
recurr
sever
persist
infect
especi
caus
unusu
opportunist
pathogen
catalas
posit
organ
chronic
granulomat
diseas
consid
tabl
differenti
np
lung
abscess
especi
import
underli
caus
treatment
differ
simpl
lung
abscess
often
run
indol
cours
fever
cough
may
present
week
becom
complic
investig
delay
multipl
thinwal
caviti
np
may
coalesc
form
one
contrastenhanc
thickwal
abscess
contain
gasfluid
level
within
area
consolid
lung
manag
np
reli
upon
expert
opinion
result
retrospect
observ
studi
mainli
singl
center
date
randomizedcontrol
trial
compar
differ
treatment
perform
multidisciplinari
team
pediatr
respiratori
physician
intensivist
thorac
surgeon
infecti
diseas
expert
often
requir
overarch
aim
control
ultim
revers
pathobiolog
chang
associ
np
includ
provid
supplement
oxygen
reliev
hypoxia
ensur
adequ
analgesia
reduc
pleurit
pain
improv
ventil
administ
prolong
antibiot
therapi
decreas
mass
effect
intrathorac
pressur
drain
ga
andor
intrapleur
fluid
correct
fluid
electrolyt
abnorm
attent
nutrit
includ
manag
hypoalbuminemia
also
import
children
requir
circulatori
ventil
support
occasion
extracorpor
membran
oxygen
ecmo
use
refractori
hypoxem
respiratori
failur
sever
ill
children
suspect
proven
aureu
pyogen
bilater
lung
involv
pulmonari
hemorrhag
impair
also
benefit
highdos
intraven
iv
immunoglobulin
infus
gkg
repeat
h
improv
prolong
cours
iv
antibiot
cornerston
therapi
initi
choic
antibiot
otherwis
healthi
fulli
immun
children
empyema
cover
gram
posit
organ
especi
pneumococci
aureu
pyogen
take
account
local
epidemiolog
microbiolog
data
consequ
recommend
firstlin
treatment
iv
penicillin
ampicillin
children
hospit
sever
uncompl
cap
need
broaden
includ
betalactam
antistaphylococc
antibiot
oxacillin
flucloxacillin
treatment
tailor
accord
microbiolog
result
although
may
posit
case
tabl
suspicion
mrsa
high
eg
local
preval
ethnic
recent
person
household
histori
skin
infect
confirm
cultur
antibiot
direct
specif
pathogen
importantli
vancomycin
penetr
poorli
lung
parenchyma
treatment
failur
occur
mrsa
pneumonia
use
monotherapi
thu
mrsa
confirm
betalactam
antistaphylococc
antibiot
part
treatment
regimen
highlevel
evid
lack
addit
agent
linezolid
clindamycin
rifampicin
capabl
inhibit
protein
synthesi
includ
toxin
product
may
result
better
outcom
aureu
pyogen
infect
np
complic
pneumonia
infect
suspect
macrolid
iv
clarithromycin
azithromycin
ad
howev
agent
invari
replac
antibiot
activ
pneumococci
aureu
given
high
rate
mix
infect
associ
pneumonia
pneumonia
frequent
neg
microbiolog
result
patient
np
increas
level
macrolid
resist
respiratori
bacteri
pathogen
final
initi
empir
antibiot
therapi
may
need
provid
extend
gram
neg
coverag
includ
third
fourth
gener
cephalosporin
child
unimmun
h
influenza
type
b
hib
immunocomprom
infect
hospitalacquir
optim
durat
antibiot
treatment
np
unknown
median
length
antibiot
cours
case
seri
list
tabl
rang
day
studi
provid
data
report
median
antibiot
cours
durat
day
switch
iv
oral
antibiot
appropri
child
afebril
least
h
longer
show
sign
sepsi
respiratori
distress
resolv
enter
feed
toler
inflammatori
marker
declin
point
antibiot
continu
least
anoth
day
recommend
align
consensu
guidelin
ppe
empyema
complic
pediatr
cap
recommend
surgic
intervent
kept
minimum
avoid
risk
bpf
alway
possibl
larg
pyopneumothorax
tension
pneumatocel
andor
locul
empyema
alreadi
present
especi
persist
lead
mass
effect
caus
hemodynam
instabl
compromis
ventil
moreov
necrot
lung
may
discov
time
surgeri
experienc
pediatr
surgeon
crucial
manag
especi
surgic
intervent
becom
less
common
children
np
europ
uk
us
tabl
particularli
challeng
risk
bleed
ecmo
use
surgeri
two
princip
aim
first
manag
concomit
pleural
diseas
involv
moder
larg
ppe
multilocul
empyema
persist
ga
leak
bpf
also
provid
opportun
collect
pleural
fluid
microbiolog
test
chest
tube
drainag
alon
larg
ppe
pyopneumothorax
may
suffic
locul
empyema
chest
tube
insert
instal
intrapleur
fibrinolyt
option
prefer
expert
howev
chest
tube
drainag
day
fibrinolyt
may
also
associ
increas
risk
bpf
develop
fail
empyema
case
surgic
intervent
either
videoassist
thoracoscop
surgeri
minithoracotomi
debrid
pyogen
materi
around
lung
decort
breakdown
locul
remov
pu
may
requir
fever
sign
sepsi
andor
respiratori
distress
continu
despit
chest
tube
insert
without
fibrinolyt
therapi
repeat
imag
show
persist
increas
intrapleur
collect
howev
pleural
diseas
minim
aforement
symptom
may
underli
np
continu
iv
antibiot
without
surgeri
recommend
bpf
pyopneumothorax
may
occur
spontan
np
relat
surgic
intervent
includ
protract
chest
tube
placement
caus
signific
morbid
ga
leak
continu
despit
prolong
drainag
surgeri
may
requir
seal
fistula
fibrin
glue
insert
muscl
flap
second
aim
surgeri
manag
progress
lung
parenchym
necrosi
involv
segment
lobar
resect
pneumonectomi
rare
requir
children
indic
surgeri
includ
massiv
hemoptysi
larg
multipl
tension
pneumatocel
pulmonari
gangren
caviti
subsequ
abscess
exceed
involv
lobe
children
np
usual
prolong
hospit
stay
median
length
stay
case
list
tabl
rang
day
surprisingli
undergo
surgeri
longer
stay
hospit
manag
conserv
despit
receiv
appropri
antibiot
therapi
drainag
accompani
ppe
empyema
children
np
often
intermitt
fever
sever
day
part
natur
histori
infect
poor
penetr
antibiot
hypoperfus
region
lung
cavit
lesion
lead
delay
bacteri
clearanc
tissu
necrosi
ongo
inflamm
nevertheless
child
remain
toxic
persist
fever
ongo
respiratori
distress
supplement
oxygen
requir
accompani
sustain
elev
inflammatori
marker
evalu
requir
determin
whether
primari
sourc
control
within
thorac
caviti
achiev
foci
infect
exist
eg
osteomyelitissept
arthriti
infect
endocarditispericard
deepseat
abscess
intravascular
line
infect
venou
thrombos
develop
case
without
microbiolog
diagnosi
incorrect
antibiot
choic
possibl
resist
organ
must
also
consid
addit
complic
worth
highlight
includ
hu
may
emerg
cours
pnp
particularli
taiwanes
children
earli
lateonset
lifethreaten
tension
pneumatocel
tension
pneumothorax
tension
pneumatocel
aris
ballvalv
mechan
trap
ga
within
caviti
late
tension
pneumothorax
may
occur
unrecogn
small
bpf
lead
lowgrad
leak
gradual
accumul
ga
within
pleural
caviti
pressur
complic
need
urgent
surgic
intervent
thu
expert
advis
children
residu
caviti
repeat
chest
radiograph
week
follow
discharg
sooner
develop
sign
respiratori
distress
unlik
adult
case
fatal
rate
np
rang
approxim
death
children
uncommon
despit
often
critic
ill
requir
manag
intens
care
unit
although
death
report
singl
case
report
small
case
seri
articl
overrepres
aureu
infect
may
subject
public
bia
studi
patient
display
tabl
two
death
report
singl
center
underw
thoracotomi
similarli
death
also
uncommon
pnp
tabl
two
death
includ
hu
pulmonari
gangren
amongst
patient
case
seri
fatal
report
largest
case
seri
publish
date
patient
made
full
clinic
recoveri
within
month
hospit
although
eight
readmit
within
week
discharg
mostli
ongo
fever
studi
children
also
followup
spirometri
eight
normal
result
mild
obstruct
defect
observ
children
mild
restrict
anoth
find
similar
hospit
sever
cap
case
chest
radiograph
ct
scan
normal
improv
markedli
month
consequ
addit
review
children
repeat
chest
radiograph
week
follow
discharg
author
recommend
clinic
review
chest
radiograph
week
month
minimum
old
enough
perform
spirometri
investig
done
discharg
month
referr
pediatr
respiratori
physician
investig
indic
symptom
radiograph
abnorm
persist
beyond
expect
time
frame
month
month
respect
greater
understand
np
occasion
complic
pneumonia
prevent
depend
upon
reduc
cap
sever
effort
focu
upon
children
age
year
highest
incid
cap
inde
sinc
year
death
cap
age
group
declin
global
fall
one
million
decreas
cap
attribut
combin
improv
hous
water
suppli
hygien
better
indoor
air
qualiti
reduc
parent
tobacco
smoke
increas
educ
breastfeed
rate
nutrit
greater
healthcar
access
vaccin
uptak
vaccin
contribut
success
global
pertussi
measl
hib
pneumococc
conjug
vaccin
despit
advanc
np
case
increas
last
two
decad
part
may
increas
physician
awar
request
chest
ct
scan
children
sever
refractori
complic
pneumonia
tempor
chang
pathogen
includ
pneumococc
serotyp
aureu
may
also
import
therefor
encourag
sinc
replac
pcv
us
franc
formul
contain
mani
serotyp
associ
np
rate
ppeempyema
children
fell
rapidli
whether
declin
also
true
np
unknown
nevertheless
replac
diseas
nonvaccin
pneumococc
serotyp
remain
potenti
problem
effect
vaccin
aureu
continu
elus
howev
effort
continu
improv
perform
accept
pertussi
influenza
vaccin
formul
candid
vaccin
pyogen
rsv
undergo
clinic
trial
matern
antenat
immun
pertussi
influenza
provid
earli
protect
young
infant
gain
wider
accept
novel
rsv
vaccin
administ
pregnanc
older
infant
also
evalu
hope
bundl
social
environment
medic
intervent
reduc
pediatr
cap
complic
np
uncommon
increasingli
recogn
sever
complic
pneumonia
previous
healthi
young
children
major
pathogen
pneumonia
aureu
diagnosi
consid
despit
appropri
antibiot
child
remain
febril
unwel
persist
sign
respiratori
distress
pneumonia
ppe
empyema
andor
bpf
improv
despit
chest
drainag
surgic
intervent
diagnosi
confirm
chest
imag
usual
ct
scan
sonographi
treatment
requir
prolong
iv
antibiot
chang
oral
medic
addit
day
child
afebril
clinic
stabl
ideal
surgic
intervent
kept
minimum
alway
possibl
mass
effect
ga
fluid
pleural
caviti
pulmonari
gangren
lead
massiv
hemoptysi
uncontrol
sepsi
difficulti
assist
ventil
nevertheless
despit
sever
mortal
children
uncommon
children
improv
clinic
within
coupl
month
radiograph
chang
larg
resolv
month
minor
left
mildli
impair
lung
function
import
target
futur
research
includ
identifi
interact
lead
diseas
improv
microbiolog
diagnost
gap
optim
medic
surgic
manag
ultim
prevent
sever
complic
pediatr
pneumonia
